PDCD1LG2 and neoplasm: It is mainly expressed on mature cytotoxic T lymphocytes 7, 8, and it can inhibit T cell function by binding with PD-L1 or PD-L2 ligand, which is mainly expressed on the surface of tumor cells, to induce immune tolerance and limit autoimmunity 9.